Upload Avatar (500 x 500)
Jianying Huang
Medical School
Wuhan University
Hubei
Language: Chinese, English
Clinical Trials
Drug Evaluation
Medical Devices
Research
Transformation
Technology
Medical Science
Innovation
Regulatory Compliance
Gcp
Areas of Focus
- Clinical evaluation of drugs and medical devices
- Medical science and technology achievement transformation research
Work Experience
- Executive Deputy Director, Office Director, Clinical Trial Center, Zhongnan Hospital, Wuhan University
Academic Background & Achievements
- Over 30 years of experience in clinical evaluation of new drugs
- Currently serves at the Clinical Trial Center of Zhongnan Hospital of Wuhan University (National Drug Clinical Trial Institution)
Publications
- Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial, Shipo Wu, Jianying Huang, et al., 2021
- Multifunctional MOF-Based Microneedle Patch With Synergistic Chemo-Photodynamic Antibacterial Effect and Sustained Release of Growth Factor for Chronic Wound Healing, Zeng YN, Wang CY, Lei K, Xiao C, Jiang X, Zhang W, Wu LJ, Huang JY, Li W, 2023
- Safety and feasibility of umbilical cord mesenchymal stem cells in patients with COVID‐19 pneumonia: A pilot study, Feng Ying, Huang Jianying, Wu Jianyuan, Xu Yan, Chen Bo, Jiang Lijun, Xiang Hui, Peng Zhiyong, Wang Xinghuan, 2020
- Simultaneous determination of abiraterone and its five metabolites in human plasma by LC-MS/MS: Application to pharmacokinetic study in healthy Chinese subjects, Yixin Hu, Jianyuan Wu, Xin Jiang, Guiying Chen, Yang Zhang, Luqin Si, Hongliang Jiang, Jiangeng Huang, Jianying Huang, 2022
- Favipiravir Versus Arbidol for Clinical Recovery Rate in Moderate and Severe Adult COVID-19 Patients: A Prospective, Multicenter, Open-Label, Randomized Controlled Clinical Trial, Chen Chang, Zhang Yi, Huang Jianying, Yin Ping, Cheng Zhenshun, Wu Jianyuan, Chen Song, Zhang Yongxi, Chen Bo, Lu Mengxin, Ju Lingao, Zhang Jingyi, Wang Xinghuan, 2021
- Effect of SHR0302 on the Pharmacokinetics of CYP3A4, CYP2C8, CYP2C9, and CYP2C19 Probe Substrates in Healthy Volunteers: A Cocktail Analysis, Fu M, Luo L, Feng S, Lin H, Lu Z, Gu F, Fan Y, Wu B, Huang J, Shen K, 2023
Awards
- National Model Worker (2021.03)
- Advanced Worker in the Provincial Association for Science and Technology System (2022.08)
- One of Hubei's Top 100 Outstanding Women in Science and Technology Innovation (2020.09)
- Advanced Individual in Wuhan's Fight Against COVID-19 Epidemic (2020)
- Second Prize, Hubei Province Science and Technology Progress Award for 'Combined Clinical Research Platform Establishment and Technological Innovation Application' (2022)
